Screening criteria set for Swedish pre-school children needs to change

Article

A Swedish initiative for screening the vision of six-years olds has found that those with a visual acuity (VA) of 0.65 rarely have defects that require treatment, making the current criterion of 0.8 too demanding on the available resources.

A Swedish initiative for screening the vision of six-years olds has found that those with a visual acuity (VA) of 0.65 rarely have defects that require treatment, making the current criterion of 0.8 too demanding on the available resources, according to a report published in the June issue of Acta Ophthalmologica Scandinavia.

Anna-Lena Hård from the Institute of Neuroscience and Physiology at Gothenburg University, Gothenburg, Sweden evaluated the new vision screening methods with particular attention to screening criteria. The current requirements state that, pre-school children with a VA <0.8 or symptoms, should be referred to eye clinics for VA testing, cover testing, cycloplegic autorefraction and ophthalmoscopy. The current screening limit of 0.8 was evaluated in relation to a limit of 0.65.

A total of 3,885 pupils underwent screening. Of these, 225 (6.6%) were referred and 236 underwent ophthalmological examination. Seventy-five percent of these were children with a VA of 0.65 in the worse eye and more than half of these were found, by the clinic, to have a VA of ≥0.8. Only 6.7% were found to have significant ammetropia.

Hård concluded that the current screening and referral criterion of 0.8 is too high, since most children with a VA of 0.65 rarely have defects requiring treatment.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.